|
ICK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.65370000418486E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.4139001908452E-10 |
| Normal-vs-Stage2 |
3.032200E-02 |
| Normal-vs-Stage3 |
2.120500E-03 |
| Normal-vs-Stage4 |
1.536400E-01 |
| Stage1-vs-Stage2 |
4.205200E-01 |
| Stage1-vs-Stage3 |
3.466400E-02 |
| Stage1-vs-Stage4 |
2.028600E-04 |
| Stage2-vs-Stage3 |
6.857600E-01 |
| Stage2-vs-Stage4 |
1.936190E-01 |
| Stage3-vs-Stage4 |
1.680210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.32660002164442E-09 |
| Normal-vs-AfricanAmerican |
4.107400E-01 |
| Normal-vs-Asian |
1.292810E-01 |
| Caucasian-vs-AfricanAmerican |
4.515500E-03 |
| Caucasian-vs-Asian |
6.190600E-01 |
| AfricanAmerican-vs-Asian |
1.024550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86680000013872E-07 |
| Normal-vs-Female |
1.54690999999429E-05 |
| Male-vs-Female |
7.980000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.721810E-01 |
| Normal-vs-Age(41-60Yrs) |
8.1573999999307E-08 |
| Normal-vs-Age(61-80Yrs) |
3.66799999995671E-06 |
| Normal-vs-Age(81-100Yrs) |
3.753000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.061600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.359600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.172400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.605800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.686390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.957200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.379400E-03 |
| Normal-vs-Grade 2 |
6.42660369365444E-11 |
| Normal-vs-Grade 3 |
1.025100E-04 |
| Normal-vs-Grade 4 |
9.131000E-01 |
| Grade 1-vs-Grade 2 |
7.214800E-01 |
| Grade 1-vs-Grade 3 |
6.635700E-02 |
| Grade 1-vs-Grade 4 |
1.138780E-03 |
| Grade 2-vs-Grade 3 |
1.103240E-03 |
| Grade 2-vs-Grade 4 |
7.14179999583564E-08 |
| Grade 3-vs-Grade 4 |
4.203300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.0325074129014E-14 |
| Normal-vs-ccB subtype |
5.805000E-03 |
| ccA subtype-vs-ccB subtype |
9.71620000012052E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.08939999979796E-07 |
| Normal-vs-N1 |
9.518200E-01 |
| N0-vs-N1 |
9.020100E-02 |
|
|
